about
How I treat influenza in patients with hematologic malignancies.Intestinal decontamination of multidrug-resistant Klebsiella pneumoniae after recurrent infections in an immunocompromised host.Stable hematopoietic cell engraftment after low-intensity nonmyeloablative conditioning in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndromeThe influence of maternal immunization on light chain response to Haemophilus influenzae type b vaccine.Emerging viral infections after hematopoietic cell transplantation.Impact of corticosteroid treatment and antiviral therapy on clinical outcomes in hematopoietic cell transplant patients infected with influenza virus.Safety of oseltamivir compared with the adamantanes in children less than 12 months of age.Viral infections in immunocompromised patients.HIV knowledge and attitudes toward HIV testing of South Side Chicago Housing Authority residents.Recommended Curriculum for Training in Pediatric Transplant Infectious Diseases.A conversation with Janet Englund, MD. Interview by Stanford T. Shulman.Transmission of methicillin-resistant Staphylococcus aureus to preterm infants through breast milk.Randomized controlled multicenter trial of aerosolized ribavirin for respiratory syncytial virus upper respiratory tract infection in hematopoietic cell transplant recipients.In search of a vaccine for respiratory syncytial virus: the saga continues.Influenza Clinical Diagnostic Testing and Antiviral Treatment among Children Hospitalized with Acute Respiratory Illness During the 2015–16 Influenza Season.Blood Viral Load (VL) Not Clinically Meaningful in Symptomatic Congenital Cytomegalovirus (cCMV) Infection.Meterology-driven Prediction of RSV/RHV Incidence in Rural Nepal.Clinical Presentation, Risk Factors, and Cross-Protection from Repeated Respiratory Viral Infections in Infants in Nepal.Respiratory Syncytial Virus-Associated Hospitalizations in Young Children in the United States, 2015–2016.Predictors of Measles and Rubella Serostatus in Mother–Infant Pairs in Rural Nepal.Who's the Target: Mother or Baby?751. Acute Respiratory Illness Hospitalizations Among Young Children: Multi-Center Viral Surveillance Network, United States, 2015–2016750. Respiratory Virus Infections and Airflow Obstruction After Allogeneic Hematopoietic Cell Transplantation1734. Cytokine Levels in Bronchoalveolar Lavage Fluid of Rhinovirus-Infected Hematopoietic Cell Transplant Recipients: Associations With Mortality721. Clinical Respiratory Syndromes and Association with Influenza Clinical Diagnostic Testing and Antiviral Treatment among Children Hospitalized with Acute Respiratory Illness, 2015–20161096. Effect of Diarrheal Illness During Pregnancy on Adverse Birth Outcomes in Nepal613. Transmission of Influenza Virus in Mother and Infant Transmission Events in Nepal1106. Infectious Etiologies of Acute Gastroenteritis in Children during the First 100 Days Post-Allogeneic Hematopoietic Cell Transplant117. Effect of Nasopharyngeal Pneumococcal Carriage on RSV and hMPV Illness Severity in Infants in Nepal871. Symptomatic Respiratory Syncytial Virus and Adenovirus Upper Respiratory Tract Infections Increase the Risk of Invasive Aspergillosis After Allogeneic Hematopoietic Cell Transplantation1553. Infectious Complications Following Hematopoietic Cell Transplantation in Patients With Primary Immunodeficiency DiseasesClinical Significance of Human Coronavirus in Bronchoalveolar Lavage Samples From Hematopoietic Cell Transplantation Recipients and Hematologic Malignancy PatientsClinical and Virologic Characterization of Children Presenting With Enterovirus-D68 Infection in Seattle, WashingtonOxygen-Free Days and Mortality Among Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus (RSV) InfectionLack of Molecular Evidence of Nosocomial Transmission of Human Rhinovirus in Hematopoietic Cell Transplant Recipients
P50
Q30383456-FEA466DE-C958-4D9D-8A34-161252F28610Q34173608-9A65ECBB-0689-4447-8F57-13C2778CCC57Q34233378-F253EAA0-DE1D-4339-B324-6CC65E46B659Q35172901-A7CF2A5F-E88D-435F-8663-FEFF14C68090Q36321258-679C7636-4B9C-49E6-A221-C02E60203ABFQ36913826-B22ED707-05D6-4C72-91ED-83115BB3420EQ36990293-D46D4B2A-37AF-45C2-9CC8-3DBFDABF21C1Q37824989-0AA0E264-7D17-41DE-A23A-44AED99BB25EQ39871855-3A89DBB5-D490-4490-8C83-4EE8B514E2C0Q40500551-3A16CBA4-DCFF-4E35-B090-60A1FFAAA9DFQ44176742-72F1FBD1-5286-488D-BFD4-22BC64DAA484Q45106860-877AB90C-6C9C-4959-9F05-DEBF9DEB65A1Q45409102-5A59844F-CAB1-411B-B309-7168E28D0EE3Q45504207-BD8A1805-E9D6-40E4-868F-CECFA7341840Q46133830-D615615B-9597-442C-9850-00825F43E27DQ46294907-743B6DC6-D19A-43DA-BF1B-52B2A40F8677Q47101608-FB65925B-3E7B-4668-ADCC-D292E13B7562Q47113625-22BFE5DC-5BA4-4002-82B0-C87FC5AF0844Q47114954-E1AB2AFB-E675-4BDE-8DC9-28000EB37F70Q47152507-7C62F3A7-B340-47DB-BD8F-2B91F1927695Q50104589-D4638BE6-A622-48C0-AD30-DD041F79F385Q59327306-D312AD7B-EDC5-426B-8E5A-E38C8FEEFA1DQ59327722-DDE82973-50F2-47B4-99F8-3E1613DF810DQ59328444-0C3C39E6-38B5-4F6A-89E4-FFEB7997C9B0Q59333432-623B1ED4-6E18-4399-875B-079F3795F551Q59333464-18605735-2025-4FCC-B801-7A83316B2FCCQ59333932-47D02345-C591-4402-B31C-EFF732A1CE75Q59334206-E0795D47-1E9E-4D0F-BC18-CDEE71426E1CQ59334432-4FA24345-479C-4E54-BDE2-ABE3054B34BAQ59334711-946A0635-45EE-416C-A3EA-B5BB4E3DFE47Q59334831-04E41F97-3578-4544-ADEF-8B4D83B86D95Q63253093-17F37311-F630-4F62-AD64-B29E0AAB1C72Q63253094-5A5B04B3-BDBE-463E-803B-B07C304E8BD8Q63253095-B8418549-E3F7-4180-B76F-50D076355613Q63253099-6039FE85-09BD-4F22-9538-889D1615A6D3
P50
name
Janet Englund
@ast
Janet Englund
@en
Janet Englund
@nl
type
label
Janet Englund
@ast
Janet Englund
@en
Janet Englund
@nl
prefLabel
Janet Englund
@ast
Janet Englund
@en
Janet Englund
@nl